• Nenhum resultado encontrado

Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis.

N/A
N/A
Protected

Academic year: 2016

Share "Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis."

Copied!
7
0
0

Texto

Loading

Referências

Documentos relacionados

Objective: We evaluated the association between vitamin D levels and nutritional status, pulmonary function and pulmonary exacerbations in children and adolescents with cystic

No entanto, com o aumento da prevalência do consumo destas substâncias entre os adolescentes portugueses (ainda que este possa não ser de forma abusiva),

Gilbert and Guerrier (1997) and Deery and Jago (2001) studied the evolution in the hospitality management and related the changes in organizational structure (today

Figura 54 Planta da proposta Atropina para o campo Base COM1 (Fonte: imagem da autora). Figura 55 Cortes e Alçados da proposta Atropina (Fonte: imagem

The authors stated that patients with significant respiratory symptoms and multiple risk factors require pulmonary function testing in order to monitor the progression of

Pulmonary disease can occur in up to 36% of these patients and The diagnostic yield and complications of open lung biopsies in kidney transplant patients with pulmonary

Objective: To determine the prevalence of pulmonary hypertension (PH) in patients with cystic fibrosis (CF), to compare clinical characteristics, radiographic

Due to better treatment regimens, the survival of these patients has been increasing, and it currently possible for cystic fibrosis patients to reach up to 35 years of